British American Security Information Council: Transatlantic Strategies For A More Secure World

*
*
Press Room
Email Updates
Publications
Getting to Zero
Nuclear Weapons
Transatlantic Security
Downloads & Links
BASIC Blogs
*
Printer Friendly Printer Friendly

BIOLOGICAL WEAPONS UPDATE

18 September 2007

In this issue:

Previous editions of Biological Weapons Update are available at: http://www.basicint.org/update/bwu.htm.

Arms Control

On August 20 the United Nations inaugurated a new unit to further bolster its efforts to reduce the threat to the international community posed by weapons of mass destruction. The Implementation Support Unit (ISU) - which will help States Parties in their efforts to bolster implementation of the Biological Weapons Convention - was launched in Geneva as part of the UN Office for Disarmament Affairs. The decision to form the ISU was taken in December 2006 at the Sixth Review Conference of the Biological Weapons Convention, and is a landmark since the Unit is the first institutional support mechanism created to support global efforts to curb biological weapons.

The Meeting of Experts from States Parties to the Biological Weapons Convention (BWC) was held in Geneva from 20 to 24 August 2007. The Meeting of Experts is the first part of a four-year program mandated by the 2006 Sixth Review Conference of the BWC aimed at strengthening the implementation of the Convention and improving its effectiveness as a practical barrier against the development or use of biological weapons. The conclusions will be drawn in the Meeting of the States Parties (10-14 December).

The Bioweapons Prevention Project produced daily reports and collected documents, working papers, presentations, and statements from the meeting. They are available here.

Further reading:

Bio-Safety in U.S. Laboratories

The Dallas Morning News reported July 28 that at least one Texas A&M University lab employee exposed to a dangerous infectious agent last year did not have federal approval to work with it. The records also show that other high-level experiments were conducted in a lab not authorized for them. The revelations are the latest in a mounting scientific scandal at A&M, stemming from the university's failure to report to the federal government one illness and several other cases of workers being exposed to "select agents."

In late July Representative Tom Davis (R-Va.) ranking Republican member of the House Oversight and Government Reform Committee, in a letter to committee Chairman Henry Waxman (D-Calif.), said the committee should investigate security at the country's most sensitive biological defense sites. "The integrity of Biosafety Level 3 and 4 laboratory procedures," Davis wrote, referring to facilities assigned to work with the most dangerous diseases, "is emerging as a critical national and homeland security issue."

The Fort Worth Star-Telegram reported August 23 that the number of U.S. university laboratories conducting research on potential bioterrorism agents has exploded in a matter of years to possibly more than 400.

Further reading:

  • Minimum Security Standards for Safeguarding Biological Select Agents and Toxins (BSAT)," Chief of Naval Operations OPNAV Instruction 5530.16, July 20, 2007.

Foot and Mouth Outbreak in the U.K.

An outbreak of foot and mouth disease virus (FMDV) was confirmed at a farm in Surrey, United Kingdom on 3 August 2007. Preliminary investigations indicated that the virus may have originated from the Pirbright site at which two separate organizations are based: the Institute for Animal Health (IAH) and Merial Animal Health Ltd (Merial). Click here for the initial investigative report.

Bio-Terrorism

The July 1 Dick Destiny blog entry details the activities of former Soviet bio-weapons expert Ken Alibek who has profited handsomely by warning of bioterrorist threats since defecting to the United States. See more in this August 12 entry.

The U.S. Homeland Security Department's three-year-old program to coordinate surveillance information on bio-terrorism is at risk of going over budget and falling behind schedule due to a lack of clear guidance and lack of data, according to a new report from the department's Inspector General (IG). Also, the National Biosurveillance Integration System, which was initiated in 2004, still does not have a plan in place to coordinate development of the necessary information technology systems, the IG wrote.

The European Commission announced August 13 that a new medical intelligence system could help the European Union to quickly detect and deal with an act of biological terrorism or natural disease outbreak. The MediSys system conducts ongoing collection and sorting of information from more than 1,100 news Web sites and 120 public health sites in 32 languages.

Further reading:

Publications

Protecting Building Occupants and Operations from Biological and Chemical Airborne Threats: A Framework for Decision Making, National Research Council 2007.

Department of Defense Chemical and Biological Defense Program," Annual

Report to Congress, April 2007.

Report on Activities and Programs for Countering Proliferation and NBC Terrorism, Counterproliferation Program Review Committee, Volume I,
Executive Summary, May 2007.

Mucosal Immunization with a Novel Nanoemulsion-Based Recombinant Anthrax Protective Antigen Vaccine Protects against Bacillus anthracis Spore Challenge, Infection and Immunity, August 2007, p. 4020-4029, Vol. 75, No. 8.

Neil Davison, 'Off the Rocker' and 'On the Floor': The Continued Development of Biochemical Incapacitating Weapons, Bradford Science and Technology Report No. 8, August 2007.

Catherine Rhodes and Malcolm Dando, The Biological Weapons Proliferation Threat: Past, Present, and Future Assessments and Responses, Strategic Insights, Volume VI, Issue 5, August 2007.

Glen Segell, The London Ricin Cell, Strategic Insights, Volume VI, Issue 5, August 2007.

Leonard A. Cole, Bioweapons, Proliferation, and the U.S. Anthrax Attack, Strategic Insights, Volume VI, Issue 5, August 2007.

*
BASIC UK: The Grayston Centre, 2nd Fl, 28 Charles Square, London N1 6HT, +44-(0)20-7324 4680
BASIC US: 110 Maryland Ave NE, Suite 205, Washington, DC 20002, +1 202 546 8055